首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Clinical And Experimental Medicine

Clinical And Experimental Medicine杂志,由Springer International Publishing出版,于2001年创刊,Quarterly,出版语言English,ISSN:1591-8890,E-ISSN:1591-9528。

投稿咨询
Clinical And Experimental Medicine
Clinical And Experimental Medicine
Clinical And Experimental Medicine
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
4.5
CiteScore
6.7
期刊收录
SCI、SCIE

Clinical And Experimental Medicine(中文译名:《临床和实验医学》),ISSN:1591-8890,EISSN:1591-9528,是Springer International Publishing出版的国际性学术期刊,创刊于2001年,以Quarterly形式稳定发行,2026年总发文量约419篇。该刊采用非OA开放访问,学科归属为医学 - 医学:研究与实验。该刊是医学、医学研究与实验领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达4.5,2025年期刊CiteScore为6.7,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Clinical And Experimental Medicine长期聚焦医学、医学研究与实验及相关产业的技术应用前沿,平均审稿周期约2.5月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、医学研究与实验领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDItaly、Poland、Brazil、Egypt、Mexico、Czech Republic等为核心发文国家与地区;UNIVERSITA DEGLI STUDI DI BARI ALDO MOROFUDAN UNIVERSITY、UNIVERSIDAD DE GUADALAJARA、BROS MERCY HOSP、COMENIUS UNIVERSITY BRATISLAVA、NANJING MEDICAL UNIVERSITY、MASARYK UNIVERSITY BRNO等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
4区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
4区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 59 / 191

69.4

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 77 / 191

59.95

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 68 / 195

65.4

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 86 / 195

56.15


中国学者近期发文

1
TIM-3 in AML: pathogenic roles and therapeutic targetabilit

Author:Zhong, Liyan; Soleimani Samarkhazan, Hamed

Journal: CLINICAL AND EXPERIMENTAL MEDICINE. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1007/s10238-026-02133-3

2
Prognostic value of the neutrophil-to-lymphocyte ratio in POEMS syndrom

Author:Zhang, Ting; Chen, Qi; Shen, Xuxing; Jin, Yuanyuan; Shen, Na; Chen, Lijuan; Xu, Ji

Journal: CLINICAL AND EXPERIMENTAL MEDICINE. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1007/s10238-026-02111-9

3
Development and validation of an interpretable machine learning model for predicting portal vein system thrombosis following splenectomy in Wilson's diseas

Author:Shen, Yi; Zheng, Zhou; Min, Hui-cong; Peng, Hui; Huang, Long; Zhang, Wan-zong; Feng, Hui; Yu, Qing-sheng

Journal: CLINICAL AND EXPERIMENTAL MEDICINE. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1007/s10238-026-02127-1

4
Neutrophil extracellular Trap-related genes in NAFLD: Biomarkers and therapeutic target

Author:Rao, Huajing; Chen, Juan; Chen, Yongcheng; Jiang, Jinfeng

Journal: CLINICAL AND EXPERIMENTAL MEDICINE. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1007/s10238-026-02139-x

5
Exploratory study of PD-1 inhibitors with or without ruxolitinib for the treatment of adult EBV-associated hemophagocytic lymphohistiocytosis: a real-world data-based preliminary investigatio

Author:Chen, Zhao; Li, Wanting; Liu, Can; Chen, Jianjun; Tan, Xi; Li, Wei; Zhou, Cheng; Li, Fang; Lei, Ping; Zhou, Ming

Journal: CLINICAL AND EXPERIMENTAL MEDICINE. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1007/s10238-026-02136-0

6
Identification of plasma exosome circRNA as potential novel biomarkers for DLBCL and circrna-miRNA-mRNA network analysi

Author:Cao, Yue; Guo, Lin; Ge, Jiao; Qiu, Yan; Wang, Fei; Li, Feng; Gu, Weiying; Lin, Yan

Journal: CLINICAL AND EXPERIMENTAL MEDICINE. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1007/s10238-025-02019-w

7
Multi-omics identification of a programmed cell death-related signature and potential target P4HB for bladder cancer based on a 101-combination machine learning and experimental validatio

Author:Cao, Yang; Li, Can; Hua, Yibo; Wu, Tingting; Shen, Qiuyu; Lin, Zeyu; Huang, Yuhua

Journal: CLINICAL AND EXPERIMENTAL MEDICINE. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1007/s10238-026-02146-y

8
S100A8-associated inflammatory microenvironment is related to its cell-of-origin and potentiates BRAF inhibitor resistance in papillary craniopharyngiom

Author:Zhao, Chuan; Lin, Yi; Chen, Huadong; Liu, Hongxing; Hu, Wenxin; Wang, Xingfu; Chen, Jintao; Luo, Ning; Qi, Xueling; Han, Song; Li, Xiaonan; Wang, Xianlong; Lin, Zhixiong

Journal: CLINICAL AND EXPERIMENTAL MEDICINE. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1007/s10238-026-02095-6

9
CD59 silencing enhances doxorubicin sensitivity in DLBCL cells and is associated with poor prognosis in patients treated with CHOP regime

Author:Linzhu; Xianmusiya, Maimaitirexiati; Wen, Shujuan; Wu, Mei; Li, Shan; Liang, Xiao

Journal: CLINICAL AND EXPERIMENTAL MEDICINE. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1007/s10238-026-02134-2

10
Development and validation of a risk prediction model and management strategy for red blood cell irregular antibodies a retrospective cohort study of 521 patient

Author:Wang, Liang; Yang, Jinjin; Guo, Zhaopei; Qiu, Dongbiao; Fu, Ya; Xu, Yongjie

Journal: CLINICAL AND EXPERIMENTAL MEDICINE. 2026; Vol. 26, Issue 1, pp. -. DOI: 10.1007/s10238-026-02142-2


在线咨询

Clinical And Experimental Medicine

国际简称:CLIN EXP MED参考译名:临床和实验医学

年发文量:419 CiteScore:6.7 是否预警:否 Gold OA文章占比:80.45% 研究类文章占比:69.45%

杂志社联系方式:SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013

Clinical And Experimental Medicine